89 related articles for article (PubMed ID: 2171561)
1. Interaction of recombinant human tumor necrosis factor and etoposide in human lung cancer cell lines.
Doyle LA; Hamburger AW; Goldstein LH; Park HJ
Mol Biother; 1990 Sep; 2(3):169-74. PubMed ID: 2171561
[TBL] [Abstract][Full Text] [Related]
2. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
3. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.
Doyle LA; Giangiulo D; Hussain A; Park HJ; Yen RW; Borges M
Cancer Res; 1989 Dec; 49(23):6745-51. PubMed ID: 2555051
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.
Munker M; Munker R; Saxton RE; Koeffler HP
Cancer Res; 1987 Aug; 47(15):4081-5. PubMed ID: 3038306
[TBL] [Abstract][Full Text] [Related]
7. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
[TBL] [Abstract][Full Text] [Related]
9. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
11. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
Gilbert JA; Frederick LM; Ames MM
Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
[TBL] [Abstract][Full Text] [Related]
12. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
15. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
Jin H; Yang R; Fong S; Totpal K; Lawrence D; Zheng Z; Ross J; Koeppen H; Schwall R; Ashkenazi A
Cancer Res; 2004 Jul; 64(14):4900-5. PubMed ID: 15256461
[TBL] [Abstract][Full Text] [Related]
16. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP
Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687
[TBL] [Abstract][Full Text] [Related]
17. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
19. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations.
Georgiadis MS; Russell EK; Gazdar AF; Johnson BE
Clin Cancer Res; 1997 Mar; 3(3):449-54. PubMed ID: 9815704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
